Togane, Japan

Syunji Horie

This inventor holds 2 USPTO granted patents. Top assignees: Chiba University, Josai University Corporation. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Syunji Horie. Retrieved from https://idiyas.com/inventor/syunji-horie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Syunji Horie: Innovator in Indole Alkaloid Derivatives

Introduction

Syunji Horie is a notable inventor based in Togane, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of indole alkaloid derivatives. With a total of 2 patents to his name, Horie's work focuses on compounds that have potential therapeutic applications.

Latest Patents

Horie's latest patents include innovative formulations of indole alkaloid derivatives that exhibit opioid receptor agonistic effects. These patents detail the synthesis of these derivatives and the therapeutic compositions that incorporate them. The methods outlined in his patents aim to treat various medical conditions using these novel compounds.

Career Highlights

Throughout his career, Syunji Horie has been associated with esteemed institutions such as Chiba University and Josai University Corporation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Horie has collaborated with notable colleagues, including Hiromitsu Takayama and Mariko Kitajima. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Syunji Horie's contributions to the field of medicinal chemistry through his patents on indole alkaloid derivatives highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…